Arteriosclerosis and Thrombosis, Vol 11, 671-680, Copyright © 1991 by American Heart Association

ARTICLES

Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis

A Mennander, S Tiisala, J Halttunen, S Yilmaz, T Paavonen and P Hayry
Fourth Department of Surgery, University of Helsinki, Finland.

Chronic rejection has several histological appearances, depending on the type of organ graft. Common to all of them is transplant arteriosclerosis associated with an ongoing inflammatory response in the transplanted graft. To the contrary of classical atherosclerosis, in which the manifestations are mostly focal, proximal, and asymmetric, transplant arteriosclerosis is generalized, and the intimal thickening is concentric. In this article, we describe an experimental animal model whereby transplant arteriosclerosis may be investigated in the inbred rat. Aortic allografts were transplanted from DA (RTIa) to major histocompatibility complex-incompatible WF (RTIv) rats or, for control, to rats of the DA strain. Transplantation was followed by an acute inflammation episode in the aortic adventitia of the allograft, largely lacking in the syngeneic graft, with a prominence of lymphoid activation markers (Cd25) in the cells of the inflammatory infiltrate. The inflammation episode peaked at 2 months after transplantation, became attenuated, and was followed by a proliferative response of myocytes in the allograft media. An increase in the migration of myocytes to the subendothelial space (presumably through small breaks generated in the internal elastic lamina) was observed thereafter, and myocyte proliferation continued in the intima with some intermingled macrophages. Finally, necrosis and disappearance of myocytes and their replacement by fibrous tissue were observed in the media. These alterations are virtually identical with the vascular lesion of chronically rejecting parenchymal organ transplants in human subjects. We suggest that aortic allografts exchanged between histoincompatible rat strains may be used as an experimental model for transplant arteriosclerosis.

This article has been cited by other articles:

				J.-B. Michel, O. Thaunat, X. Houard, O. Meilhac, G. Caligiuri, and A. Nicoletti Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1259 - 1268. [Abstract] [Full Text] [PDF]

				O. Thaunat, A.-C. Field, J. Dai, L. Louedec, N. Patey, M.-F. Bloch, C. Mandet, M.-F. Belair, P. Bruneval, O. Meilhac, et al. Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response PNAS, October 11, 2005; 102(41): 14723 - 14728. [Abstract] [Full Text] [PDF]

				G. J. Murphy and M. L. Nicholson Rapamycin has no effect on fibrosis-associated gene expression or extracellular matrix accumulation when administered to animals with established or early allograft vasculopathy J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2058 - 2064. [Abstract] [Full Text] [PDF]

				C. Dambrin, J. Klupp, T. Birsan, J. Luna, T. Suzuki, T. Lam, P. Stahr, B. Hausen, U. Christians, P. Fitzgerald, et al. Sirolimus (Rapamycin) Monotherapy Prevents Graft Vascular Disease in Nonhuman Primate Recipients of Orthotopic Aortic Allografts Circulation, May 13, 2003; 107(18): 2369 - 2374. [Abstract] [Full Text] [PDF]

				S. Sartore, A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni, and P. Pauletto Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant Circ. Res., December 7, 2001; 89(12): 1111 - 1121. [Abstract] [Full Text] [PDF]

				E. Andriambeloson, M. Bigaud, E. O. Schraa, T. Kobel, V. Lobstein, C. Pally, and Hans-Gunter Zerwes Endothelial Dysfunction and Denudation in Rat Aortic Allografts Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 67 - 73. [Abstract] [Full Text] [PDF]

				J. F. Legare, T. D.G. Lee, K. Creaser, and D. B. Ross T lymphocytes mediate leaflet destruction and allograft aortic valve failure in rats Ann. Thorac. Surg., October 1, 2000; 70(4): 1238 - 1245. [Abstract] [Full Text] [PDF]

				J.-F. Legare, T. Issekutz, T. D. G. Lee, and G. Hirsch CD8+ T Lymphocytes Mediate Destruction of the Vascular Media in a Model of Chronic Rejection Am. J. Pathol., September 1, 2000; 157(3): 859 - 865. [Abstract] [Full Text] [PDF]

				J. Fukada, S. Schena, I. Tack, P. Ruiz, Y. Kurimoto, M. Pang, A. Aitouche, T. Abe, L. J. Striker, and S. M. Pham FK409, a Spontaneous Nitric Oxide Releaser, Attenuates Allograft Vasculopathy in a Rat Aortic Transplant Model Circ. Res., July 7, 2000; 87(1): 66 - 72. [Abstract] [Full Text] [PDF]

				M. V. Autieri, C. Carbone, and A. Mu Expression of Allograft Inflammatory Factor-1 Is a Marker of Activated Human Vascular Smooth Muscle Cells and Arterial Injury Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1737 - 1744. [Abstract] [Full Text] [PDF]

				G. M. Hirsch, J. Kearsey, T. Burt, M. J. Karnovsky, and T. Lee Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis Eur. J. Cardiothorac. Surg., July 1, 1999; 14(1): 89 - 97. [Abstract] [Full Text] [PDF]

				A. Raisanen-Sokolowski, T. Glysing-Jensen, and M. E. Russell Leukocyte-Suppressing Influences of Interleukin (IL)-10 in Cardiac Allografts : Insights from IL-10 Knockout Mice Am. J. Pathol., November 1, 1998; 153(5): 1491 - 1500. [Abstract] [Full Text] [PDF]

				D. Bouchard, M.-A. Despatis, J. Buluran, and R. Cartier Vascular Effects of Cyclosporin A and Acute Rejection in Canine Heart Transplantation Ann. Thorac. Surg., November 1, 1997; 64(5): 1325 - 1330. [Abstract] [Full Text]

				J. Waltenberger, M. L. Akyurek, M. Aurivillius, A. Wanders, E. Larsson, B. Fellstrom, and K. Funa Ischemia-Induced Transplant Arteriosclerosis in the Rat: Induction of Peptide Growth Factor Expression Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1516 - 1523. [Abstract] [Full Text]

				K. B. Lemstrom, A. K. Raisanen-Sokolowski, P. J. Hayry, and P. K. Koskinen Triple Drug Immunosuppression Significantly Reduces Aortic Allograft Arteriosclerosis in the Rat Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 553 - 564. [Abstract] [Full Text]

				G. M. LaMuraglia, F. Adili, T. Schmitz-Rixen, N. A. Michaud, and T. J. Flotte Photodynamic Therapy Inhibits Experimental Allograft Rejection : A Novel Approach for the Development of Vascular Bioprostheses Circulation, October 1, 1995; 92(7): 1919 - 1926. [Abstract] [Full Text]

				J. D. Hosenpud, J. P. Everett, T. E. Morris, K. A. Mauck, G. D. Shipley, and C. R. Wagner Cardiac Allograft Vasculopathy : Association With Cell-Mediated but Not Humoral Alloimmunity to Donor-Specific Vascular Endothelium Circulation, July 15, 1995; 92(2): 205 - 211. [Abstract] [Full Text]